Inside Angle

From 3M Health Information Systems

Tag: DRGs

DRGs (Diagnosis Related Groups) is a methodology for classifying patients based on the amount and type of hospital resources needed to treat them. Countries use DRGs or similar classification systems to allocate scarce resources, to determine reimbursement and funding and to measure the quality of care provided by hospitals. DRGs link clinical and financial data, and provide an operational means to define case mix (the range and type of patients a hospital treats). Most developed nations have adopted classification systems as the basis of their payment and quality measurement; many of these methodologies, including DRGs, were developed by 3M. The use of DRGs requires diagnosis and procedure coding, both primary businesses of 3M. This is an example of a language that enables communication across all entities involved in the delivery of healthcare.

Video: A shift toward quality focus

Amy Truitt and Debbie Okonek, CDI leaders at Palmetto Health, discuss their organization’s shift toward quality focus.

Introducing competition and price transparency into the Medicare payment system

November 1st, 2017 / By Richard Averill, MS, Richard Fuller, MS

Would an Amazon-like price shopping experience for individual healthcare services help control healthcare costs? Price transparency is frequently cited as a possible strategy for reducing the cost of healthcare because […]

Article: Embrace risk adjustment

With Donna Smith, RHIA

This article details how coders can enhance their careers by becoming proficient in the finer points of the latest payment methodologies.

Sepsis 3 Consensus definitions—the impact on quality (part two)

June 10th, 2016 / By Cheryl Manchenton, RN

In my previous blog, I addressed concerns about the new Sepsis 3 definitions.  In this blog (part 2), I will further flush out implications for specific quality metrics and also […]

Controlling the cost of pharmaceuticals through the EAPG payment system

October 16th, 2015 / By Norbert Goldfield, MD, Richard Fuller, MS

In a recent blog we made the case for quantifying the net effect of drugs upon health expenditures so as to make more rational decisions. Providing information about costs and […]

HIMagine That! The 3M Client Experience Summit

May 22nd, 2015 / By Sue Belley, RHIA, Donna Smith, RHIA

Donna: Hi Sue! I had a great week at the 3M Client Experience last week! How about you? Sue: Me, too! It was so nice meeting customers face-to-face and hearing […]

Integrating Sociodemographic Factors into Risk Adjustment: Important Considerations for NQF’s “Robust Trial Period”

October 22nd, 2014 / By Norbert Goldfield, MD, Richard Fuller, MS

Why is it necessary that risk adjustment incorporate sociodemographic factors for my diabetic schizophrenic patients who have unstable housing? Healthcare is fundamentally about people. That’s why, at the end of […]

The Real Impact of DRGs: Meaningful Data that Changed Hospital Management

July 17th, 2014 / By Richard Averill, MS

A recent blog by François de Brantes, executive director of HCI3, titled “Letting the Facts Get in the Way of So-called Truths,” is highly critical of the DRG based Medicare […]

Readmission Perspectives Part Two: Warranty Rewards for Improved Readmission Rates

August 26th, 2013 / By Norbert Goldfield, MD, Richard Fuller, MS

Two separate articles on readmission policy by Drs. Ashish Jha and Robert Berenson, recently published in the New England Journal of Medicine, give us the opportunity to review differing perspectives […]